Whei-Lin Pan Pi-Lun Chen Cho-Ying Lin Yi-Chun Pan Yuh-Ren Ju Chiu-Po Chan Robert Ww Hsu
10.2147/CIA.S141753
Clin Interv Aging
2017 Jul 11;12:1089-1093.
bronj bisphosphonate-related osteonecrosis of the jaw bisphosphonates strontium ranelate
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/28744112/
Alendronate / adverse effects Bisphosphonate-Associated Osteonecrosis of the Jaw / drug therapy Bone Density Conservation Agents / adverse effects Osteoporosis, Postmenopausal / drug therapy Thiophenes / therapeutic use
Alendronate / adverse effects Bisphosphonate-Associated Osteonecrosis of the Jaw / drug therapy Bone Density Conservation Agents / adverse effects Osteoporosis, Postmenopausal / drug therapy Thiophenes / therapeutic use Case Reports Aged, 80 and over Alendronate / therapeutic use Bisphosphonate-Associated Osteonecrosis of the Jaw / diagnosis Bisphosphonate-Associated Osteonecrosis of the Jaw / etiology Bone Density Conservation Agents / therapeutic use Diphosphonates / adverse effects Female Humans Postmenopause Bone Density Conservation Agents Diphosphonates Thiophenes strontium ranelate Alendronate
PMC5513807
28744112
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
2017